• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕洛诺司琼与其他止吐药物与 5-羟色胺 5-HT3 受体的结合。

The Binding of Palonosetron and Other Antiemetic Drugs to the Serotonin 5-HT3 Receptor.

机构信息

CNRS, Univ. Grenoble Alpes, CEA, IBS, 38000 Grenoble, France.

Research Center for Analytical Sciences, College of Chemistry, Nankai University, Tianjin Key Laboratory of Biosensing and Molecular Recognition, Tianjin 300071, People's Republic of China.

出版信息

Structure. 2020 Oct 6;28(10):1131-1140.e4. doi: 10.1016/j.str.2020.07.004. Epub 2020 Jul 28.

DOI:10.1016/j.str.2020.07.004
PMID:32726573
Abstract

Inaccurately perceived as niche drugs, antiemetics are key elements of cancer treatment alleviating the most dreaded side effect of chemotherapy. Serotonin 5-HT3 receptor antagonists are the most commonly prescribed class of drugs to control chemotherapy-induced nausea and vomiting. These antagonists have been clinically successful drugs since the 1980s, yet our understanding of how they operate at the molecular level has been hampered by the difficulty of obtaining structures of drug-receptor complexes. Here, we report the cryoelectron microscopy structure of the palonosetron-bound 5-HT3 receptor. We investigate the binding of palonosetron, granisetron, dolasetron, ondansetron, and cilansetron using molecular dynamics, covering the whole set of antagonists used in clinical practice. The structural and computational results yield detailed atomic insight into the binding modes of the drugs. In light of our data, we establish a comprehensive framework underlying the inhibition mechanism by the -setron drug family.

摘要

止吐药常被误解为利基药物,却是癌症治疗的关键要素,可缓解化疗最令人恐惧的副作用。5-羟色胺 5-HT3 受体拮抗剂是最常被开处用于控制化疗引起的恶心和呕吐的药物。自 20 世纪 80 年代以来,这些拮抗剂一直是临床成功的药物,但由于难以获得药物-受体复合物的结构,我们对它们在分子水平上如何运作的理解一直受到阻碍。在这里,我们报告了与帕洛诺司琼结合的 5-HT3 受体的冷冻电镜结构。我们使用分子动力学研究了帕洛诺司琼、格拉司琼、多拉司琼、昂丹司琼和盐酸兰地司琼的结合情况,涵盖了临床上使用的整套拮抗剂。结构和计算结果提供了药物结合模式的详细原子见解。根据我们的数据,我们建立了一个全面的框架,阐述了 -setron 药物家族的抑制机制。

相似文献

1
The Binding of Palonosetron and Other Antiemetic Drugs to the Serotonin 5-HT3 Receptor.帕洛诺司琼与其他止吐药物与 5-羟色胺 5-HT3 受体的结合。
Structure. 2020 Oct 6;28(10):1131-1140.e4. doi: 10.1016/j.str.2020.07.004. Epub 2020 Jul 28.
2
High-resolution structures of multiple 5-HTR-setron complexes reveal a novel mechanism of competitive inhibition.多个5-羟色胺受体-血清素复合物的高分辨率结构揭示了一种竞争性抑制的新机制。
Elife. 2020 Oct 16;9:e57870. doi: 10.7554/eLife.57870.
3
Palonosetron-5-HT Receptor Interactions As Shown by a Binding Protein Cocrystal Structure.帕洛诺司琼与 5-HT 受体相互作用的结合蛋白晶体结构。
ACS Chem Neurosci. 2016 Dec 21;7(12):1641-1646. doi: 10.1021/acschemneuro.6b00132. Epub 2016 Sep 22.
4
Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor.帕洛诺司琼与5-羟色胺3(5-HT3)受体表现出独特的分子相互作用。
Anesth Analg. 2008 Aug;107(2):469-78. doi: 10.1213/ane.0b013e318172fa74.
5
Theoretical evaluation of antiemetic effects of 5-HT3 receptor antagonists for prevention of vomiting induced by cisplatin.5-HT3受体拮抗剂预防顺铂所致呕吐的止吐作用的理论评价
Eur J Drug Metab Pharmacokinet. 2015 Mar;40(1):39-44. doi: 10.1007/s13318-014-0175-z. Epub 2014 Jan 28.
6
Prolonged inhibition of 5-HT₃ receptors by palonosetron results from surface receptor inhibition rather than inducing receptor internalization.帕洛诺司琼对5-HT₃受体的长期抑制是由表面受体抑制引起的,而非诱导受体内化。
Br J Pharmacol. 2013 Jul;169(6):1252-62. doi: 10.1111/bph.12204.
7
Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.帕洛诺司琼:一种独特的5-羟色胺3(5-HT3)受体拮抗剂,用于预防化疗引起的急性和迟发性恶心及呕吐。
Clin Adv Hematol Oncol. 2004 May;2(5):284-9.
8
5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy.用于预防化疗引起的恶心和呕吐的5-羟色胺3(5-HT3)受体拮抗剂。其药理学与临床疗效比较
Drugs. 1998 Feb;55(2):173-89. doi: 10.2165/00003495-199855020-00002.
9
Comparison of two different intravenous serotonin antagonists used for chemotherapy-induced nausea and vomiting prophylaxis in patients treated with moderately emetogenic risk regimens: A retrospective analysis from a large academic medical center.比较两种不同的静脉用 5-羟色胺拮抗剂在接受中度致吐风险方案治疗的患者中的化疗引起的恶心和呕吐预防作用:来自大型学术医疗中心的回顾性分析。
J Oncol Pharm Pract. 2020 Dec;26(8):1964-1969. doi: 10.1177/1078155220938847. Epub 2020 Jul 6.
10
Molecular mechanisms of 5-HT(3) and NK(1) receptor antagonists in prevention of emesis.5-HT(3) 和 NK(1) 受体拮抗剂预防呕吐的分子机制。
Eur J Pharmacol. 2014 Jan 5;722:26-37. doi: 10.1016/j.ejphar.2013.08.049. Epub 2013 Oct 31.

引用本文的文献

1
Structural characterisation of a cysteine-rich conotoxin, sigma(σ)S-GVIIIA, extracted from the defensive venom of the marine cone snail Conus geographus.从海洋芋螺Conus geographus的防御性毒液中提取的富含半胱氨酸的芋螺毒素sigma(σ)S-GVIIIA的结构表征。
Biochem J. 2025 Apr 23;482(11):639-53. doi: 10.1042/BCJ20240753.
2
Discovering cryptic pocket opening and binding of a stimulant derivative in a vestibular site of the 5-HT receptor.发现一种兴奋剂衍生物在前庭5-羟色胺受体位点的隐秘口袋开口和结合情况。
Sci Adv. 2025 Apr 11;11(15):eadr0797. doi: 10.1126/sciadv.adr0797.
3
Mapping the molecular motions of 5-HT serotonin-gated channel by voltage-clamp fluorometry.
通过电压钳荧光法绘制 5-HT 血清素门控通道的分子运动图谱。
Elife. 2024 Jun 24;12:RP93174. doi: 10.7554/eLife.93174.
4
Structural determinants for activity of the antidepressant vortioxetine at human and rodent 5-HT receptors.抗抑郁药文拉法辛在人和啮齿动物 5-HT 受体活性的结构决定因素。
Nat Struct Mol Biol. 2024 Aug;31(8):1232-1242. doi: 10.1038/s41594-024-01282-x. Epub 2024 May 2.
5
Structural basis for partial agonism in 5-HT receptors.5-HT 受体部分激动作用的结构基础。
Nat Struct Mol Biol. 2024 Apr;31(4):598-609. doi: 10.1038/s41594-023-01140-2. Epub 2024 Jan 4.
6
Efficiently Differentiating Agonists and Competitive Antagonists for Weak Allosteric Protein-Ligand Interactions with Linear Response Theory.利用线性响应理论有效区分弱变构蛋白-配体相互作用中的激动剂和竞争性拮抗剂。
ACS Omega. 2023 Nov 15;8(47):44537-44544. doi: 10.1021/acsomega.3c03503. eCollection 2023 Nov 28.
7
Superiority of the Triple-Acting 5-HTR/5-HTR Antagonist and MAO-B Reversible Inhibitor over 5-HTR Antagonist Intepirdine in Alleviation of Cognitive Deficits in Rats.三重作用 5-HT1A/5-HT1D 受体拮抗剂和 MAO-B 可逆抑制剂优于 5-HT 拮抗剂依替皮啶对大鼠认知功能障碍的改善作用。
J Med Chem. 2023 Nov 9;66(21):14928-14947. doi: 10.1021/acs.jmedchem.3c01482. Epub 2023 Oct 5.
8
The Role of Ion Channels in Functional Gastrointestinal Disorders (FGID): Evidence of Channelopathies and Potential Avenues for Future Research and Therapeutic Targets.离子通道在功能性胃肠疾病(FGID)中的作用:通道病的证据和未来研究及治疗靶点的潜在途径。
Int J Mol Sci. 2023 Jul 4;24(13):11074. doi: 10.3390/ijms241311074.
9
5-HT Receptors on Mitochondria Influence Mitochondrial Function.5-羟色胺受体对线粒体的影响。
Int J Mol Sci. 2023 May 5;24(9):8301. doi: 10.3390/ijms24098301.
10
Recent Insight into Lipid Binding and Lipid Modulation of Pentameric Ligand-Gated Ion Channels.五聚体配体门控离子通道的脂质结合与脂质调节的最新见解
Biomolecules. 2022 Jun 10;12(6):814. doi: 10.3390/biom12060814.